JP2020534270A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020534270A5 JP2020534270A5 JP2020514950A JP2020514950A JP2020534270A5 JP 2020534270 A5 JP2020534270 A5 JP 2020534270A5 JP 2020514950 A JP2020514950 A JP 2020514950A JP 2020514950 A JP2020514950 A JP 2020514950A JP 2020534270 A5 JP2020534270 A5 JP 2020534270A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- sleep
- effective amount
- composition
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims description 19
- 230000007958 sleep Effects 0.000 claims description 13
- 206010022437 Insomnia Diseases 0.000 claims description 10
- 239000002775 capsule Substances 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 4
- 239000000546 pharmaceutic aid Substances 0.000 claims description 4
- 231100000486 side effect Toxicity 0.000 claims description 4
- 230000037322 slow-wave sleep Effects 0.000 claims description 4
- 206010062519 Poor quality sleep Diseases 0.000 claims description 2
- 230000004620 sleep latency Effects 0.000 claims description 2
- 230000004622 sleep time Effects 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 25
- 230000000694 effects Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 2
- 238000006011 modification reaction Methods 0.000 description 2
- 208000009025 Nervous System Disease Diseases 0.000 description 1
- 206010053643 Neurodegenerative disease Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023008782A JP2023038310A (ja) | 2017-09-14 | 2023-01-24 | １９－ノルｃ３，３－二置換ｃ２１－ｎ－ピラゾリルステロイドおよびその使用方法 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762558703P | 2017-09-14 | 2017-09-14 | |
| US62/558,703 | 2017-09-14 | ||
| US201862624678P | 2018-01-31 | 2018-01-31 | |
| US201862624680P | 2018-01-31 | 2018-01-31 | |
| US62/624,680 | 2018-01-31 | ||
| US62/624,678 | 2018-01-31 | ||
| US201862653189P | 2018-04-05 | 2018-04-05 | |
| US62/653,189 | 2018-04-05 | ||
| PCT/US2018/051048 WO2019055764A1 (en) | 2017-09-14 | 2018-09-14 | C21-N-PYRAZOLYL C3,3-DISUBSTITUTED STEROID 19 NOR, AND METHODS OF USING THE SAME |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023008782A Division JP2023038310A (ja) | 2017-09-14 | 2023-01-24 | １９－ノルｃ３，３－二置換ｃ２１－ｎ－ピラゾリルステロイドおよびその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020534270A JP2020534270A (ja) | 2020-11-26 |
| JP2020534270A5 true JP2020534270A5 (US07981874-20110719-C00313.png) | 2021-10-28 |
Family
ID=65723895
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020514950A Pending JP2020534270A (ja) | 2017-09-14 | 2018-09-14 | １９−ノルｃ３，３−二置換ｃ２１−ｎ−ピラゾリルステロイドおよびその使用方法 |
| JP2023008782A Pending JP2023038310A (ja) | 2017-09-14 | 2023-01-24 | １９－ノルｃ３，３－二置換ｃ２１－ｎ－ピラゾリルステロイドおよびその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023008782A Pending JP2023038310A (ja) | 2017-09-14 | 2023-01-24 | １９－ノルｃ３，３－二置換ｃ２１－ｎ－ピラゾリルステロイドおよびその使用方法 |
Country Status (9)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2806877T (pt) | 2012-01-23 | 2019-12-06 | Sage Therapeutics Inc | Formulações de esteroides neuroativos que compreendem um complexo de alopregnanolona e beta-ciclodextrinas de éter sulfobutílico |
| WO2015195962A1 (en) | 2014-06-18 | 2015-12-23 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| RS60343B1 (sr) | 2014-11-27 | 2020-07-31 | Sage Therapeutics Inc | Kompozicije i postupci za lečenje poremećaja cns-a |
| EP3504189A1 (en) | 2016-08-23 | 2019-07-03 | Sage Therapeutics, Inc. | A crystalline 19-nor c3, 3-disubstituted c21-n-pyrazolyl steroid |
| US20200291059A1 (en) | 2017-12-08 | 2020-09-17 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| US10857163B1 (en) | 2019-09-30 | 2020-12-08 | Athenen Therapeutics, Inc. | Compositions that preferentially potentiate subtypes of GABAA receptors and methods of use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3498725T (pt) * | 2013-04-17 | 2021-09-09 | Sage Therapeutics Inc | Esteroides c21-n-pirazolilo 19-nor c3,3-dissubstituídos para uso em terapia |
| RS60642B1 (sr) * | 2014-10-16 | 2020-09-30 | Sage Therapeutics Inc | Kompozicije i postupci za lečenje poremećaja cns-a |
| EP3504189A1 (en) * | 2016-08-23 | 2019-07-03 | Sage Therapeutics, Inc. | A crystalline 19-nor c3, 3-disubstituted c21-n-pyrazolyl steroid |
-
2018
- 2018-09-14 IL IL303083A patent/IL303083A/en unknown
- 2018-09-14 JP JP2020514950A patent/JP2020534270A/ja active Pending
- 2018-09-14 EP EP23150618.9A patent/EP4218767A1/en active Pending
- 2018-09-14 CA CA3075872A patent/CA3075872A1/en active Pending
- 2018-09-14 MX MX2020002889A patent/MX2020002889A/es unknown
- 2018-09-14 TW TW111150395A patent/TW202339764A/zh unknown
- 2018-09-14 EP EP18786464.0A patent/EP3681510A1/en not_active Withdrawn
- 2018-09-14 TW TW107132510A patent/TW201919642A/zh unknown
- 2018-09-14 US US16/647,203 patent/US20220110949A1/en not_active Abandoned
- 2018-09-14 WO PCT/US2018/051048 patent/WO2019055764A1/en unknown
- 2018-09-14 AU AU2018334214A patent/AU2018334214A1/en active Pending
-
2020
- 2020-03-08 IL IL273126A patent/IL273126A/en unknown
- 2020-03-13 MX MX2023010064A patent/MX2023010064A/es unknown
- 2020-03-13 MX MX2023010063A patent/MX2023010063A/es unknown
-
2023
- 2023-01-24 JP JP2023008782A patent/JP2023038310A/ja active Pending
- 2023-03-01 US US18/176,571 patent/US20230201224A1/en active Pending
